Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-10 Sale | 2020-08-12 8:01 pm | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $88.61 | $531,665 | 44,699 (Direct) | View |
| 2020-05-07 Sale | 2020-05-08 8:05 pm | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $60.16 | $360,941 | 33,415 (Direct) | View |
| 2020-02-10 Sale | 2020-02-12 7:03 pm | Principia Biopharma Inc. | PRNB | Goldstein David Chief Scientific Officer | 6,000 | $70.9 | $425,400 | 39,415 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Option Award | 2024-07-01 4:38 pm | N/A 2032-01-26 | ALUMIS INC. | ALMS | Goldstein David M Chief Scientific Officer | 732,968 | $0 | 519,065 (Direct) | View |
| 2024-07-01 Disposition | 2024-07-01 4:38 pm | N/A 2032-01-26 | ALUMIS INC. | ALMS | Goldstein David M Chief Scientific Officer | 732,968 | $0 | 519,065 (Direct) | View |
Ownership | 2024-06-27 4:05 pm | N/A N/A | ALUMIS INC. | ALMS | Goldstein David M Chief Scientific Officer | 0 | $0 | 732,968 (Indirect) | View |
| 2020-09-28 Disposition | 2020-09-28 5:08 pm | N/A 2024-06-26 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 286,117 | $0 | 0 (Direct) | View |
| 2020-09-28 Equity Swap | 2020-09-28 5:08 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 31,826 | $100 | 0 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 3,553 | $3.1794 | 44,699 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $0 | 44,699 (Direct) | View |
| 2020-08-10 Exercise | 2020-08-12 8:01 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 2,447 | $2.9977 | 44,699 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-08 8:05 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $0 | 33,415 (Direct) | View |
| 2020-05-07 Exercise | 2020-05-08 8:05 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer | 6,000 | $2.9977 | 33,415 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:24 pm | N/A 2030-03-04 | Principia Biopharma Inc. | PRNB | Goldstein David Chief Scientific Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-12 7:03 pm | N/A 2023-10-23 | Principia Biopharma Inc. | PRNB | Goldstein David Chief Scientific Officer | 6,000 | $0 | 39,415 (Direct) | View |
| 2020-02-10 Exercise | 2020-02-12 7:03 pm | N/A N/A | Principia Biopharma Inc. | PRNB | Goldstein David Chief Scientific Officer | 6,000 | $2.9977 | 39,415 (Direct) | View |